Skip to main content

4 Result(s)

within Jacques Bruhwyler Remove this filter

and

  1. Article

    Open Access

    Patient-Reported Outcomes with Insulin Glargine 300 U/mL in People with Type 2 Diabetes: The MAGE Multicenter Observational Study

    MAGE was a Multicenter, single-Arm, observational 6-month (plus 6-month extension) study that aimed to assess treatment satisfaction, efficacy, and safety of insulin Glargine 300 U/mL (Gla-300) in people with ...

    Ides M. Colin, Kathy Alexandre, Jacques Bruhwyler, André Scheen… in Diabetes Therapy (2020)

    Download PDF (358 KB) View Article

  2. Article

    Open Access

    Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study

    OPTIMIZE evaluated the efficacy, safety and treatment satisfaction of insulin glargine 300 U/mL once daily (Gla-300 OD) in people with type 1 diabetes mellitus (T1DM) previously uncontrolled on basal insulin t...

    Chantal Mathieu, S. John Weisnagel, Peter Stella, Jacques Bruhwyler… in Diabetes Therapy (2020)

    Download PDF (660 KB) View Article

  3. Article

    Open Access

    Comorbidities and survival in patients with chronic hypersensitivity pneumonitis

    Chronic Hypersensitivity Pneumonitis (cHP) is a fibrotic interstitial lung disease (ILD) resulting from repeated exposure to an offending antigen. Prognostication in cHP remains challenging, and the relationsh...

    Julia Wälscher, Benjamin Gross, Julie Morisset, Kerri A. Johannson… in Respiratory Research (2020)

    Download PDF (1020 KB) View Article

  4. No Access

    Article

    The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates

    Rationale: Neuroleptic or antipsychotic drugs are the mainstay of treating acute and chronic psychosis. However, their efficacy is offset by a wide array of side effects, especially extrapyramid...

    Daniel E. Casey, Jacques Bruhwyler, Jacques Delarge, Joseph Géczy… in Psychopharmacology (2001)